ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 28 filers reported holding ANNOVIS BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94,900 | -33.6% | 10,000 | 0.0% | 0.00% | -40.0% |
| Q2 2023 | $142,900 | -7.3% | 10,000 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $154,100 | +14.7% | 10,000 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $134,300 | -2.0% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $137,000 | +21.2% | 10,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $113,000 | -15.7% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $134,000 | -23.9% | 10,000 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $176,000 | -65.8% | 10,000 | -38.3% | 0.01% | -68.8% |
| Q3 2021 | $514,000 | -62.5% | 16,200 | +1.2% | 0.02% | -61.0% |
| Q2 2021 | $1,369,000 | +390.7% | 16,000 | +60.0% | 0.04% | +355.6% |
| Q1 2021 | $279,000 | +272.0% | 10,000 | 0.0% | 0.01% | +350.0% |
| Q4 2020 | $75,000 | +56.2% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $48,000 | +9.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $44,000 | +46.7% | 10,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $30,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 119,538 | $575,000 | 0.47% |
| Sterling Investment Advisors, Ltd. | 51,038 | $245,000 | 0.09% |
| Independence Advisors, LLC | 45,598 | $219,000 | 0.05% |
| Cannell & Co. | 10,000 | $48,000 | 0.00% |
| Paloma Partners Management Co | 17,164 | $83,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 14,286 | $69,000 | 0.00% |
| BROWN ADVISORY INC | 14,942 | $72,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 13,300 | $64,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,236 | $6,000 | 0.00% |